Skip to main content

Adda Nathalie's Form 4 filing

Enanta Pharmaceuticals Inc (ENTA) · filed Dec 3, 2021

Accession no.
0001062993-21-012213
Filed
Dec 3, 2021
Trade date
Dec 1, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.17M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Adda NathalieCIK 0001646976Officer (Sr. VP & Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 1, 2021Common StockFTax withholdingDisposed−842$87.68−$73,826.5632,902Direct
Dec 1, 2021Common StockMOption exerciseAcquired+8,750$43.46+$380,27541,652Direct
Dec 1, 2021Common StockMOption exerciseAcquired+4,773$48.52+$231,585.9646,425Direct
Dec 1, 2021Common StockSSaleDisposed−1,587$84.81−$134,593.4744,838Direct
Dec 1, 2021Common StockSSaleDisposed−5,736$85.49−$490,370.6439,102Direct
Dec 1, 2021Common StockSSaleDisposed−2,700$86.45−$233,41536,402Direct
Dec 1, 2021Common StockSSaleDisposed−1,500$87.60−$131,40034,902Direct
Dec 1, 2021Common StockSSaleDisposed−900$88.31−$79,47934,002Direct
Dec 1, 2021Common StockSSaleDisposed−899$89.33−$80,307.6733,103Direct
Dec 1, 2021Common StockSSaleDisposed−201$90.17−$18,124.1732,902Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 1, 2021Common StockMOption exerciseDisposed−8,750$0.00$046,020Direct
Dec 1, 2021Common StockMOption exerciseDisposed−4,773$0.00$09,180Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)